SageView Advisory Group LLC Has $305,000 Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

SageView Advisory Group LLC lessened its stake in HCA Healthcare, Inc. (NYSE:HCA) by 34.5% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 751 shares of the company’s stock after selling 395 shares during the quarter. SageView Advisory Group LLC’s holdings in HCA Healthcare were worth $305,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Quantinno Capital Management LP raised its holdings in shares of HCA Healthcare by 55.9% in the 3rd quarter. Quantinno Capital Management LP now owns 31,750 shares of the company’s stock worth $12,904,000 after purchasing an additional 11,380 shares during the period. Quarry LP increased its holdings in HCA Healthcare by 42.3% in the 3rd quarter. Quarry LP now owns 1,360 shares of the company’s stock worth $553,000 after acquiring an additional 404 shares during the last quarter. Motley Fool Asset Management LLC boosted its position in HCA Healthcare by 4.9% during the third quarter. Motley Fool Asset Management LLC now owns 12,228 shares of the company’s stock worth $4,958,000 after purchasing an additional 572 shares during the period. IHT Wealth Management LLC purchased a new stake in shares of HCA Healthcare during the 3rd quarter valued at approximately $207,000. Finally, Integrated Wealth Concepts LLC grew its stake in HCA Healthcare by 8.9% in the 3rd quarter. Integrated Wealth Concepts LLC now owns 3,685 shares of the company’s stock valued at $1,498,000 after buying an additional 302 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on the company. Cantor Fitzgerald reissued an “overweight” rating and set a $392.00 price objective on shares of HCA Healthcare in a report on Tuesday, October 1st. Royal Bank of Canada boosted their price target on shares of HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a research report on Friday, August 23rd. StockNews.com cut HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. Oppenheimer boosted their price objective on HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a report on Monday, October 28th. Finally, UBS Group lifted their target price on shares of HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a research report on Wednesday, August 14th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, HCA Healthcare presently has an average rating of “Moderate Buy” and an average target price of $380.29.

Insider Buying and Selling

In related news, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the transaction, the executive vice president now owns 29,678 shares in the company, valued at $11,438,494.76. The trade was a 21.97 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of HCA Healthcare stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the sale, the insider now directly owns 6,843 shares in the company, valued at approximately $2,415,579. The trade was a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 15,155 shares of company stock valued at $5,608,990 over the last ninety days. 1.60% of the stock is owned by insiders.

HCA Healthcare Price Performance

Shares of HCA Healthcare stock opened at $319.75 on Friday. The stock has a market capitalization of $80.99 billion, a P/E ratio of 14.36, a price-to-earnings-growth ratio of 1.25 and a beta of 1.63. HCA Healthcare, Inc. has a one year low of $252.85 and a one year high of $417.14. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00. The business’s 50 day simple moving average is $363.85 and its two-hundred day simple moving average is $358.61.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be given a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.83%. The ex-dividend date is Friday, December 13th. HCA Healthcare’s payout ratio is 11.85%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.